Interview with Lyanne a type 1 Diabetic who stared in the new Diabetes UK film.
From the 74th Scientific Sessions in San Francisco, Rhonda Anderson interviews Joshua Thaler, MD, PhD, one of the first recipients of the Pathway to Stop Diabetes research grants. His work focuses on changes in the brain in obesity that may affect body weight and blood glucose balance.
Diabetes is the largest cause of lower-limb amputation outside trauma.
Diabetics patients are at risk of infections which if left un-checked can lead to serious complications, if their feet are not cared for properly.
It is therefore vital that people with diabetes receive the care necessary, to help them look after their feet.
This short film tells patients about the importance of looking after their feet and how to do it, while professionals are shown how to check feet for potential problems.
Biomechanic Reference: http://astore.amazon.com/nichogiovi-20
Popular Running Shoes: http://astore.amazon.com/nichogiovi-2...
Dr. Glass DPM Podiatry Resource Network
This video illustration depicts the ankle joint complex which includes the tibial talar and subtalar joint in human anatomy.
Dr. Glass DPM - This is an illustration that depicts the cardinal plane movements of the lower extremity. This is a biomechanical demonstration of the functional orthopedic nature of podiatry
ADA TV asked attendees of the 76th Scientific Sessions in New Orleans, Louisiana how the association has meaningfully influenced their life and career.
島野 仁 先生 / Stephan Jacob 先生
The Diabetic Complications research group at the University of Michigan has created an organic, integrated and novel approach to the study of so-called “microvascular” complications of diabetes, the complications that primarily lead to the excess morbidity and mortality of diabetes.
For the past decade, this team has built its investigations upon direct evidence from humans with these complications, using novel “systems biology” and bioinformatics tools to identify the critical molecular abnormalities for each complication: nephropathy, neuropathy and retinopathy. This ability to identify major new players in the complex progression of these diseases has allowed the group to confirm their importance in disease models and to test the ability of novel treatments to reverse or prevent these devastating complications.
The complementary expertise and highly interactive style of the researchers, has allowed the University of Michigan Medical School to move from bedside to bench and back to bedside with new diagnostic and therapeutic tools that will help all patients with diabetes better understand their individual risks and how to treat and prevent diabetic retinopathy, neuropathy and nephropathy.
ADA TV was honored to interview David Marrero, PhD, about his huge role as one of ADA’s chief spokespeople. We ask Dr. Marrero at the 75th ADA Scientific Sessions about his biggest challenges and priorities currently.
Lorrie Kirshenbaum, PhD, talks with Kunhua Song, PhD, Outstanding Early Career Award Finalist for BCVS 2015 about his study, "High Efficiency Reprogramming of Fibroblasts into Cardiomyocytes Requires Suppression of Pro-fibrotic Signaling"
In type 1 diabetes, the human body turns on itself. The immune systems of people with type 1 diabetes start attacking insulin-producing beta cells, as though they were the bacteria and viruses the immune system is supposed to fight off.
Researchers at Joslin Diabetes Center are puzzling out what causes the immune system to turn on what it's meant to protect. The lab of Tom Serwold, Ph.D. studies why T cells, the immune system warriors, mistake beta cells for the enemy.
Read more here: http://blog.joslin.org/2013/09/4407/
Mark Creager, MD, president of the American Heart Association, interviews Gary Gibbons, director, NHLBI/NIH, about his keynote lecture, "Building on the NHLBI Legacy of Hypertension Research: Charting Our Future Together," which he presented at Hypertension 2015 in Washington, DC. The address focused on recent advances like the SPRINT trial and other opportunities for collaboration between the NHLBI and the AHA both past and present.
Joseph Italiano, PhD, interviews Binggang Xiang, one of the ATVB/PVD 2015 finalists for the Kenneth M. Brinkhous Young Investigator Prize in Thrombosis Competition, about his study, "Characterization of a Novel Integrin Binding Protein that is Essential for αIIbβ3 Outside-in Signaling and Hemostatsis."
第3回は、BOTのメリットとBOTに適したインスリンの特徴を、大阪市立総合医療センターの細井 雅之 先生にご説明いただきます。
第2回は、低血糖の回避と血糖コントロールの改善におけるランタスXRの有用性を、前回に引き続き横浜市立大学の寺内 康夫 先生にご説明いただきます。